Evidence map›Paper›PMID 35645188›Full record

ArticleBiomimetics (Basel, Switzerland)2022

Degradation of Hybrid Drug Delivery Carriers with a Mineral Core and a Protein-Tannin Shell under Proteolytic Hydrolases.

Polina A Demina, Mariia S Saveleva, Roman A Anisimov, Ekaterina S Prikhozhdenko, Denis V Voronin, Anatolii A Abalymov, Kirill A Cherednichenko, Olesya I Timaeva, Maria V Lomova

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Antitumor Effects of MicroencapsulatedMaterials (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Polina A DeminaScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.ORCID 0000-0002-9203-582X
Mariia S SavelevaScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.
Roman A AnisimovScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.
Ekaterina S PrikhozhdenkoScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.ORCID 0000-0003-2700-168X
Denis V VoroninScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.ORCID 0000-0002-1960-6737
Anatolii A AbalymovScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.ORCID 0000-0002-3957-2706
Kirill A CherednichenkoDepartment of Physical and Colloid Chemistry, National University of Oil and Gas «Gubkin University», Leninsky Prospekt 65, 119991 Moscow, Russia.ORCID 0000-0002-1868-8232
Olesya I TimaevaNational Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Maria V LomovaScience Medical Centre, Saratov State University, Astrakhanskaya St. 83, 410012 Saratov, Russia.ORCID 0000-0002-7464-1754
Saratov State University · RUGubkin Russian State University of Oil and Gas · RUKurchatov Institute · RU

Funding

Russian Science Foundation 19-73-10123
6 · The paper itself

Abstract

Hybrid carriers with the mineral CaCO

Indexed as

calcium carbonatedegradationdrug delivery systemspolyphenolproteinproteolytic enzymetannic acid

Identifiers

PMID35645188
PMCPMC9149959
OpenAlexW4280552532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.